» Download Article

Authors
Kariv, Galia; Shani, Vered; Goldberg, Elad; Leibovici, Leonard; Paul, Mical

Identifier
10.3182/20090812-3-DK-2006.00060

Index Terms
Cellular and molecular systems

Abstract
Background: Opportunistic pulmonary infections are a major cause of morbidity and mortality among solid organ transplant recipients. The diagnosis of these infections is challenging because of the broad spectrum of bacteria, fungi and viruses affecting these patients. Treatment directed at the offending organism started as soon as possible improves survival. Objective: To develop a decision support system for the diagnosis of pulmonary infections in solid-organ transplant recipients. The model's goal is to improve the accuracy of the diagnosis and thus the appropriateness of empirical treatment. Design: The model is built using a Bayesian network (also known as Causal Probabilistic Network). The network is based on pathogen segments which are the main building blocks of the model. All segments share common risk factors, such as time after transplantation, latent infections of donor/ recipient and organ transplanted. The segments are linked at symptoms, signs and diagnostic tests common to all pathogens. The outputs of the model are predicted probabilities of infectious pathogens. To populate the model with data we have mainly abstracted data from the literature, using a systematic approach. The structure of the model and its adaptation for decision support will be presented. Evaluation: The first evaluation phase assessed the model's diagnosis in a series of 20 representative cases of opportunistic infections. A match between the case’s diagnosis and the model’s prediction was achieved in 17/20 of cases. The next evaluation phase will consist of a prospective observational study comparing the accuracy of the model's diagnosis vs. that of the physician within 24 hours of episode onset, as compared with a gold-standard diagnosis ascribed to the patients at the end of the infectious episode by two independent experts. Data for this phase are currently collected prospectively.

References

Annual Report. 2007 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1997-2006. Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD.
Cainelli F, Vento S. Infections and solid organ transplant rejection: a cause-and-effect relationship? Lancet Infect Dis 2002; 2: 539-549.
Evans RS, Classen DC, Pestotnik SL, Lundsgaarde HP, Burke JP. Improving empiric antibiotic selection using computer decision support. Arch Intern Med 1994; 154: 878-884.
Evans RS, Pestotnik SL, Classen DC, et al. A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med 1998; 338: 232-238.
Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med. 1998 Jun 11;338(24):1741-51.
Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med. 2007 Dec 20;357(25):2601-14.
Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, Jimenez-Jimenez FJ, Perez-Paredes C, Ortiz-Leyba C. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003; 31: 2742-51.
Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 115: 529-35.
Husain S, Paterson DL, Studer SM, Crespo M, Pilewski J, Durkin M, Wheat JL, Johnson B, McLaughlin L, Bentsen C, McCurry KR, Singh N. Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation. 2007 May 27;83(10):1330-6.
Ison MG, Fishman JA.Cytomegalovirus pneumonia in transplant recipients. Clin Chest Med. 2005 Dec;26(4):691-705, viii.
Kofoed K, Zalounina A, Andersen O, Lisby G, Paul M, Leibovici L, Andreassen S. Performance of the TREAT decision support system in an environment with a low prevalence of resistant pathogens. J Antimicrob Chemother. 2009 Feb;63(2):400-4. Epub 2008 Dec 17.
Leibovici L, Gitelman V, Yehezkelli Y, et al. Improving empirical antibiotic treatment: prospective, nonintervention testing of a decision support system. J Intern Med 1997; 242: 395-400.
Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD: The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern.Med 1998; 244: 379-386.
Leibovici L, Paul M, Nielsen AD, Tacconelli E, Andreassen S. The TREAT project: decision support and prediction using causal probabilistic networks. Int J Antimicrob Agents. 2007 Nov;30 Suppl 1:S93-102. Epub 2007 Sep 24.
Patel R, Paya CV. Infections in solid-organ transplant recipients. Clin Microbiol Rev 1997; 10: 86-124.
Paul M, Andreassen S, Tacconelli E, Nielsen AD, Almanasreh N, Frank U, Cauda R, Leibovici L; TREAT Study Group. Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial. J Antimicrob Chemother. 2006 Dec;58(6):1238-45. Epub 2006 Sep 23.
Paul M, Nielsen AD, Goldberg E, Andreassen S, Tacconelli E, Almanasreh N, Frank U, Cauda R, Leibovici L; TREAT Study Group. Prediction of specific pathogens in patients with sepsis: evaluation of TREAT, a computerized decision support system. J Antimicrob Chemother. 2007 Jun;59(6):1204-7. Epub 2007 Apr 21.
Rubin RH, Schaffner A, Speich R. Introduction to the Immunocompromised Host Society consensus conference on epidemiology, prevention, diagnosis, and management of infections in solid-organ transplant patients. Clin Infect Dis 2001; 33 Suppl 1: S1-4.
Sanroman Budino B, Vazquez Martul E, Pertega Diaz S, Veiga Barreiro A, Carro Rey E, Mosquera Reboredo J. Autopsy-determined causes of death in solid organ transplant recipients. Transplant Proc 2004; 36: 787-789.
Yu VL, Fagan LM, Wraith SM, et al. Antimicrobial selection by a computer. A blinded evaluation by infectious diseases experts. Jama 1979; 242: 1279-1282.